As of November 17, 2009 the Tispa Medical process "Method for Histoprocessing" is covered by a US Patent. The patent registration can be found under patent number 7618828.
This patent opens up opportunities to enter the US medical market and to exclusively license production of the equipment in the US. This is valuable information for investors in this field and with that a step forwards for Tispa Medical in becoming a global player that's here to stay!
Tispa Medical invites you to their booth 5b37 to introduce you to the new non-toxic tissue processor.
With the installation of the first Tispa Processor in their pathology laboratory, the Erasmus MC takes an important step in eliminating the use of toxic solvents.
On May 16 Tispa Medical will actively participate in the workshop organised by the Dutch branche organisation FHI. The workshop is sub-titled:
Diagnostics in pathology - Roadmap to the future.
The workshop features scientific introductions by Prof. Dr. R.R. de Krijger of Erasmus Medical Centre on practical experiences of the pathologist tissue diagnosis, with an emphasis on streamlining the workflow.
Sanbio BV will inform us on developments of Biotech companies to new developments in pathology, mainly on moleclar research.
Dr. E. Schuuring of the University Medical Centre Groningen (UMCG) will elaborate on the scientific side of molecular pathology.
The Dutch Pathology days, 'Pathologendagen', will be held this year on April 14 and 15 in the beautiful venue of Hotel Figi in Zeist.
Tispa Medical will participate as sponsor to promote and introduce the Tispa Processor I. This processor is the first in the world to eliminate the toxic and dangerous so-called 'clearing phase' in tissue processing with a patented application of harmless CO2 (carbon dioxide).
Tispa Medical Rapid Processing - Safe, clean and fast
The best possible results on all types of tissue and all types of staining, both routine H&E and (immuno) histochemical. Excellent results on PCR extraction and other molecular techniques.